1. Home
  2. ONON vs MEDP Comparison

ONON vs MEDP Comparison

Compare ONON & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo On Holding AG

ONON

On Holding AG

HOLD

Current Price

$37.40

Market Cap

12.0B

ML Signal

HOLD

Logo Medpace Holdings Inc.

MEDP

Medpace Holdings Inc.

HOLD

Current Price

$417.34

Market Cap

11.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ONON
MEDP
Founded
2010
1992
Country
Switzerland
United States
Employees
N/A
6300
Industry
Shoe Manufacturing
Biotechnology: Commercial Physical & Biological Resarch
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.0B
11.9B
IPO Year
2021
2016

Fundamental Metrics

Financial Performance
Metric
ONON
MEDP
Price
$37.40
$417.34
Analyst Decision
Strong Buy
Hold
Analyst Count
20
12
Target Price
$60.15
$473.17
AVG Volume (30 Days)
5.7M
458.7K
Earning Date
05-12-2026
04-22-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
20.98
EPS
N/A
4.28
Revenue
N/A
N/A
Revenue This Year
$19.58
$13.19
Revenue Next Year
$19.98
$7.75
P/E Ratio
$56.05
$98.26
Revenue Growth
N/A
N/A
52 Week Low
$31.41
$287.17
52 Week High
$61.29
$628.92

Technical Indicators

Market Signals
Indicator
ONON
MEDP
Relative Strength Index (RSI) 58.28 39.23
Support Level $34.38 $412.35
Resistance Level $37.89 $435.15
Average True Range (ATR) 1.45 11.85
MACD 0.30 0.52
Stochastic Oscillator 96.68 47.13

Price Performance

Historical Comparison
ONON
MEDP

About ONON On Holding AG

Founded in Switzerland in 2010, sportswear firm On Holding generates 93% of its sales from athletic shoes. The brand is best known for its running shoes and its distinctive CloudTec soles. On also produces athletic apparel (6% of sales) and accessories (1%). The firm's merchandise is available in more than 80 countries and is sold through both wholesale (58% of sales) and company-owned channels (42%). In 2025, On generated 58% of its sales in North America, 25% in Europe, the Middle East, and Africa, and 17% in the Asia-Pacific region.

About MEDP Medpace Holdings Inc.

Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.

Share on Social Networks: